Provided by Tiger Trade Technology Pte. Ltd.

Sarepta Therapeutics

18.79
-0.4300-2.24%
Post-market: 19.150.3600+1.92%19:34 EDT
Volume:1.67M
Turnover:31.88M
Market Cap:1.98B
PE:-14.28
High:19.73
Open:19.39
Low:18.66
Close:19.22
52wk High:25.32
52wk Low:14.68
Shares:105.57M
Float Shares:99.05M
Volume Ratio:0.66
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3161
EPS(LYR):-7.1300
ROE:-9.48%
ROA:-1.13%
PB:1.30
PE(LYR):-2.64

Loading ...

Sarepta Therapeutics (SRPT) Gets a Hold from RBC Capital

TIPRANKS
·
May 07

BUZZ-Sarepta falls on lower quarterly sales for gene therapy

Reuters
·
May 07

Sarepta Therapeutics Shares Slump 13.2% Premarket to $20 After Q1 Results

THOMSON REUTERS
·
May 07

Stock Track | Sarepta Therapeutics Plunges 6.86% Pre-Market on Disappointing Q1 Revenue and Sharp ELEVIDYS Sales Decline

Stock Track
·
May 07

Stock Track | Sarepta Therapeutics Plunges 5.17% After-Hours on Disappointing Q1 Results and Sharp ELEVIDYS Sales Decline

Stock Track
·
May 07

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

Dow Jones
·
May 07

Stock Track | Sarepta Therapeutics Plunges 5.38% After-Hours on Disappointing Q1 Revenue and ELEVIDYS Sales Decline

Stock Track
·
May 07

Sarepta Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 07

Sarepta Therapeutics Q1 revenue falls on lower ELEVIDYS sales

Reuters
·
May 07

Sarepta Therapeutics Fall in Extended Trade Following Results, Last Down 7.6% at $21.27

THOMSON REUTERS
·
May 07

Sarepta Therapeutics Q1 Adj. EPS $3.16 Beats $0.99 Estimate, Sales $730.803M Beat $474.155M Estimate

Benzinga Earnings
·
May 07

Sarepta Q1 net income swings to USD 331 million; revenue slips 2% to USD 730.8 million

Reuters
·
May 07

Sarepta Therapeutics Inc - Q1 2026 Net Product Revenues Total $330.5 Mln

THOMSON REUTERS
·
May 07

Sarepta Therapeutics Inc: Reiterate FY 2026 Guidance Total Net Product Revenues of $1.2 - $1.4 Bln

THOMSON REUTERS
·
May 07

Sarepta Therapeutics Inc Q1 Shr View $0.99, REV View $474.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
May 07

U.S. Stocks to Watch: AMD, Intel, SMCI, Arista, Lucid, Novo Nordisk, and More

Dow Jones
·
May 06

Earning Preview: Sarepta Therapeutics this quarter’s revenue is expected to decrease by 30.61%, and institutional views are neutral

Earnings Agent
·
Apr 30

Analysts’ Top Healthcare Picks: Precision BioSciences (DTIL), Sarepta Therapeutics (SRPT)

TIPRANKS
·
Apr 23

Sarepta to report first-quarter results, host conference call

Reuters
·
Apr 22

Sarepta Therapeutics to Announce First Quarter 2026 Financial Results

THOMSON REUTERS
·
Apr 22